Taiwan company initiates clinical trial of drug to treat COVID

Taipei, April 21 (CNA) The third-phase clinical trial of a drug to treat patients with COVID-19 has officially begun amid a surge in COVID-19 cases in Taiwan, Taiwanese pharmaceutical company PharmaEssentia Corp., the drug's manufacturer, announced Wednesday.

Related Keywords

National Taiwan University Hospital ,T Ai Pei ,Taiwan ,Taipei ,South Korea ,Han ,Taiwanese ,Evelyn Kao ,Taiwan Ministry Of Health ,Pharmaessentia Corp ,Taiwan Ministry ,Shuang Ho Hospital ,Taoyuan General Hospital ,Han Ting ,